CARMI, Caterina
 Distribuzione geografica
Continente #
EU - Europa 765
NA - Nord America 700
AS - Asia 279
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.745
Nazione #
US - Stati Uniti d'America 683
CN - Cina 214
FI - Finlandia 188
SE - Svezia 136
IE - Irlanda 130
IT - Italia 128
DE - Germania 75
UA - Ucraina 66
TR - Turchia 28
AT - Austria 25
IN - India 20
CA - Canada 17
BE - Belgio 12
SG - Singapore 12
CZ - Repubblica Ceca 2
JP - Giappone 2
VN - Vietnam 2
EU - Europa 1
GB - Regno Unito 1
IR - Iran 1
LU - Lussemburgo 1
RO - Romania 1
Totale 1.745
Città #
Chandler 161
Dublin 130
Jacksonville 89
Parma 77
Ann Arbor 68
Dearborn 54
Beijing 49
Ashburn 43
Nanjing 29
Izmir 27
San Mateo 27
Vienna 25
Shanghai 24
Princeton 23
New York 22
Wilmington 17
Pune 15
Toronto 15
Helsinki 14
Shenyang 14
Bremen 13
Kunming 12
Brussels 11
Hefei 11
Los Angeles 11
Hebei 10
Nanchang 10
Düsseldorf 9
Boardman 8
Jinan 7
Prata Di Pordenone 7
Tianjin 7
Des Moines 5
Ardea 4
Changsha 4
Jiaxing 4
Montegaldella 4
Fremont 3
Fuzhou 3
Seattle 3
Zhengzhou 3
Augusta 2
Borås 2
Brno 2
Dong Ket 2
Highland Park 2
Houston 2
Lübeck 2
Milan 2
Norwalk 2
Reggio Nell'emilia 2
Singapore 2
Xian 2
Ankara 1
Atlanta 1
Braunschweig 1
Caorso 1
Casalgrande 1
Chengdu 1
Chongqing 1
Chuxiong 1
Esslingen am Neckar 1
Fornovo Di Taro 1
Frankfurt am Main 1
Geislingen an der Steige 1
Grafing 1
Guangzhou 1
Haikou 1
Hangzhou 1
Huzhou 1
Lanzhou 1
Leuven 1
Lissone 1
Luxembourg 1
Montreal 1
Ningbo 1
Quzhou 1
Redmond 1
Rome 1
Sassuolo 1
Taizhou 1
Taranto 1
Tokyo 1
Utsunomiya 1
Woodbridge 1
Totale 1.128
Nome #
Benzisothiazolinone Derivatives as Potent Allosteric Monoacylglycerol Lipase Inhibitors That Functionally Mimic Sulfenylation of Regulatory Cysteines 129
Dibasic biphenyl H(3) receptor antagonists: Steric tolerance for a lipophilic side chain. 104
Irreversible Inhibition of Epidermal Growth Factor Receptor Activity by 3-Aminopropanamides. 100
Amino acid derivatives as palmitoylethanolamide prodrugs: Synthesis, in vitro metabolism and in vivo plasma profile in rats 93
5-Benzylidene-hydantoins as new EGFR inhibitors with antiproliferative activity 86
Novel Irreversible Epidermal Growth Factor Receptor Inhibitors by Chemical Modulation of the Cysteine-Trap Portion 85
Biphenyl-3-yl alkylcarbamates as fatty acid amide hydrolase (FAAH) inhibitors: steric effects of N-alkyl chain on rat plasma and liver stability 84
Chiral Recognition of Flexible Melatonin Receptor Ligands Induced by Conformational Equilibria 83
5-Benzylidene-hydantoins: synthesis and antiproliferative activity on A549 lung cancer cell line 82
Antiproliferative and proapototic effects of a new combi-molecule on non small cell lung cancer cell lines 79
Meccanismo d’azione di UPR 1024: un nuovo farmaco con attività antiproliferativa in cellule di carcinoma polmonare umano 78
Toward the Definition of Stereochemical Requirements for MT(2)-Selective Antagonists and Partial Agonists by Studying 4-Phenyl-2-propionamidotetralin Derivatives. 76
A critical cysteine residue in monoacylglycerol lipase is targeted by a new class of isothiazolinone-based enzyme inhibitors. 75
Clinical perspective for irreversible tyrosine kinase inhibitors in cancer 73
N-(Anilinoethyl)amides: design and synthesis of metabolically stable, selective melatonin receptor ligands 70
New strategies to overcome resistance to EGFR tyrosine kinase inhibitors in non small cell lung cancer 68
Irreversible EGFR inhibitor compounds with antiproliferative activity 64
Molecular mechanisms underlying the antitumor activity of 3-aminopropanamide irreversible inhibitors of the epidermal growth factor receptor in non-small cell lung cancer 64
Epidermal Growth Factor Receptor Irreversible Inhibitors: Chemical Exploration of the Cysteine-Trap Portion 62
Mannich base derivatives as novel EGFR irreversible inhibitors 49
Long-lasting inhibition of EGFR autophosphorylation in A549 tumor cells by intracellular accumulation of non-covalent inhibitors 49
Solution Phase Parallel Synthesis of S-DABO Analogues 47
Parallel Solution-Phase Synthesis of 1,5-disubstitued Hydantoins as New Protein Tyrosine Kinase Inhibitors 40
Parallel Solution-phase and Microwave-assisted Synthesis of New S-DABO Derivatives Endowed with Subnanomolar Anti-HIV-1 Activity 37
Totale 1.777
Categoria #
all - tutte 5.349
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.349


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201932 0 0 0 0 0 0 0 0 0 0 32 0
2019/2020335 47 64 18 2 28 37 46 8 27 26 9 23
2020/2021221 1 18 30 2 34 12 28 8 35 10 27 16
2021/2022144 6 9 5 7 7 2 22 23 7 13 10 33
2022/2023576 58 73 45 53 60 67 5 33 157 3 15 7
2023/2024164 12 11 1 5 12 60 22 14 5 9 13 0
Totale 1.777